PDAC cells can impair tumor antigen presentation by reducing the expression of major histocompatibility complex-1 molecules and induce apoptosis of T cells by increasing the production of indoleamine 2,3-dioxygenase [151,152]. This evidence concerns the gene IDO2 and neoplasm.